Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 5;18(1):209.
doi: 10.1186/s13071-025-06854-4.

PD-1-dependent therapeutic effect of Trichinella spiralis cystatin on myocardial infarction in a mice model

Affiliations

PD-1-dependent therapeutic effect of Trichinella spiralis cystatin on myocardial infarction in a mice model

Weixiao Zhang et al. Parasit Vectors. .

Abstract

Background: Ischemia-induced inflammation is the primary pathological mechanism underlying cardiac tissue injury caused by myocardial infarction (MI). Trichinella spiralis cystatin (Ts-Cys) has been shown to regulate macrophage polarization and alleviate various inflammatory and immune-related diseases. Programmed cell death-1 (PD-1) is a crucial checkpoint receptor molecule and highly involved in maintaining immune tolerance. In this study, our aims were to investigate whether recombinant Ts-Cys protein (rTs-Cys) could be used to treat MI with recruited macrophage-dominant myocardial inflammation and whether PD-1 is involved in the immunomodulation of Ts-Cys in inflammatory diseases.

Methods: MI models were established in wild-type (WT) and PD-1 knockout (PD-1-/-) mice, followed by the intraperitoneal injection of rTs-Cys. The survival rates of mice were observed for 28 days post-surgery and treatment. Cardiac function was assessed by echocardiography. Histopathological evaluation of heart tissue affected by infarction was conducted to examine local inflammatory cell infiltration and cardiac tissue damage. Real-time quantitative PCR was used to detect messenger RNA expression levels of vascular endothelial growth factor (VEGF) and the macrophage surface markers inducible nitric oxide synthase and arginase-1 in the MI area. Serological levels of cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), were measured using an enzyme-linked immunosorbent assay. Bone marrow-derived macrophages from WT and PD-1-/- mice were used to assess the effects of rTs-Cys on macrophage polarization in vitro.

Results: In WT mice, rTs-Cys treatment significantly improved the 28-day survival rate and cardiac function, reduced local inflammatory cell infiltration and cardiac pathological damage and increased VEGF expression levels of MI mice. The therapeutic effect of rTs-Cys was associated with macrophage polarization from the pro-inflammatory M1 phenotype to the regulatory M2 phenotype with reduced levels of inflammatory cytokines (TNF-α and IL-6) and increased levels of regulatory cytokines (IL-10 and TGF-β), as determined by both in vivo and in vitro tests. However, this therapeutic effect of rTs-Cys on MI was significantly reduced in PD-1-/- mice, as reflected by the higher level of M1 macrophages, elevated levels of inflammatory cytokines and decreased levels of regulatory cytokines.

Conclusions: rTs-Cys promotes M2-type polarization of macrophages through the PD-1 pathway to alleviate MI in mice and is, therefore, a potential drug for the treatment of MI and other inflammation-related diseases with involvement of the PD-1 checkpoint molecule.

Keywords: Trichinella spiralis; Immunomodulation; Inflammation; Macrophage; Myocardial infarction; PD-1.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: All animal experimental procedures are complied with the ethical guidelines of Bengbu Medical University and were approved by the Ethics Committee (Approval No. [2023]587). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Identification of knockout of the programmed death-1 (PD-1) in PD-1−/− mice by PCR with PD-1-specific primers. Lanes: bp, size of DNA ladder; 0, blank control; 1–9, mouse number. PD-1−/−, programmed PD-1 knockout mice; WT, wild-type mice
Fig. 2
Fig. 2
Treatment with rTs-Cys significantly improved the survival rate of MI mice with PD-1 expression. The 28-day survival rate of each group of mice after surgery and treatment (n = 20) is shown. Asterisks indicate a statistically significant difference in survival rate between groups at *P < 0.05 and **P < 0.01; ns, not significant. MI, Myocardial infarction; PBS, phosphate-buffered saline; PD-1−/−, programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; WT, wild-type mice
Fig. 3
Fig. 3
Treatment with rTs-Cys significantly improved the SV, LVEF and LVFS in MI mice with PD-1 expression. a Typical B-mode ultrasound image in mice from different groups. b Typical M-mode ultrasound image in mice from different groups. c Cardiac function parameters in different groups (n = 6). The results are presented as the mean ± standard error of the mean (SEM). Asterisks indicate a statistically significant difference in the respective parameter at *P < 0.05, **P < 0.01 and ***P < 0.001; ns, not significant. LVEF, Left ventricular ejection fraction; LVFS, left ventricular fractional shortening; MI, myocardial infarction; PBS, phosphate-buffered saline; PD-1−/−, programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; SV, stroke volume; WT, wild-type mice
Fig. 4
Fig. 4
Treatment with rTs-Cys significantly reduced histopathological damage in the hearts of MI mice with PD-1 expression. a Representative shape of the heart from the different groups of mice. b Representative Masson staining sections of infarcted heart tissues from the different groups of mice (magnification 15× and 200×). c Percentage of left ventricular infarction area. d Left ventricular infarct wall thickness. The results are presented as the mean ± standard error of the mean (SEM) (n = 6). Asterisks indicate a statistically significant difference between groups at **P < 0.01 and ***P < 0.001; ns, not significant. MI, Myocardial infarction; PBS, phosphate-buffered saline; PD-1−/−,programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; WT, wild-type mice
Fig. 5
Fig. 5
Hematoxylin/eosin (HE) staining of representative heart tissue sections within the infarcted area of the heart from the different groups of mice 7 days after the MI operation and treatment (magnification 200×, scale bar: 100 μm). MI, Myocardial infarction; PBS, phosphate-buffered saline; PD-1−/−, programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; WT, wild-type mice
Fig. 6
Fig. 6
Transcriptional levels of vascular endothelial growth factor (VEGF) in the MI area of hearts from the different groups of mice relative to glyceraldehyde 3-phosphate dehydrogenase (GADPH) measured by real-time quantitative PCR. The results are presented as the mean ± standard error of the mean (SEM) (n = 6). Asterisks indicate a statistically significant difference at **P < 0.01; ns, not significant. MI, Myocardial infarction; mRNA, messenger RNA; PBS, phosphate-buffered saline; PD-1−/−, programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; VEGF, vascular endothelial growth factor; WT, wild-type mice
Fig. 7
Fig. 7
rTs-Cys regulated inflammatory-related cytokine expression. a Serological levels of the pro-inflammatory cytokines TNF-α and IL-6 and regulatory cytokines IL-10 and TGF-β, as measured by quantitative enzyme-linked immunosorbent assay. b The messenger RNA transcriptional levels of TNF-α, IL-6, IL-10 and TGF-β relative to glyceraldehyde 3-phosphate dehydrogenase (GADPH) in infarcted heart tissue, as measured by real-time quantitative PCR. The results are presented as the mean ± standard error of the mean (SEM) (n = 6). Asterisks indicate a statistically significant difference at *P < 0.05 and ***P < 0.001; ns, not significant. IL, Interleukin; MI, myocardial infarction; PBS, phosphate-buffered saline; PD-1−/−, programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; VEGF, vascular endothelial growth factor; WT, wild-type mice
Fig. 8
Fig. 8
rTs-Cys-induced PD-1-dependent M2 macrophage polarization in infarcted heart tissues. a Relative mRNA expression level of iNOS and Arg-1 in the infarcted cardiac tissues of WT and PD-1−/− mice. The results are presented as the mean ± standard error of the mean (SEM) (n = 6). Asterisks indicate a statistically significant difference at *P < 0.05, **P < 0.01 and ***P < 0.001; ns, not significant. b Representative immunofluorescence staining of cardiac tissue sections from the MI zone in the different groups at 7 days post-surgery and treatment. Scale bars: 1×, 1000 μm; 10×, 100 μm. Arg-1, Arginase-1; iNOS, inducible nitric oxide synthase; MI, myocardial infarction; mRNA, messenger RNA; PBS, phosphate-buffered saline; PD-1−/−, programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; VEGF, vascular endothelial growth factor; WT, wild-type mice
Fig. 9
Fig. 9
Levels of inflammatory cytokines (TNF-α and IL-6) and regulatory cytokines (IL-10 and TGF-β) in the supernatant of BMDMs derived from WT and PD-1−/− mice co-incubated with LPS with or without rTs-Cys, as measured by quantitative enzyme-linked immunosorbent assay. The results are presented as the mean ± standard error of the mean (SEM). Asterisks indicate a statistically significant difference at *P < 0.05, **P < 0.01 and ***P < 0.001; ns, not significant. BMDMs, Bone marrow-derived macrophages, IL, interleukin; LPS, lipopolysaccharide; MI, myocardial infarction; PBS, phosphate-buffered saline; PD-1−/−, programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; TGF-β, transforming growth factor-beta; TNF-α, tumor necrosis factor-alpha; WT, wild-type mice
Fig. 10
Fig. 10
Flow cytometry was performed to detect CD86 (M1 phenotype) and CD206 (M2 phenotype) glycoproteins on BMDMs derived from both WT and PD-1−/− mice, co-incubated with LPS and rTs-Cys. The results are presented as the mean ± standard error of the mean (SEM) (n = 3). Asterisks indicate a statistically significant difference at *P < 0.05, **P < 0.01 and ***P < 0.001; ns, not significant. BMDMs, Bone marrow-derived macrophages; FITC, fluorescein isothiocyanate; FSC, SSC, forward and side scatter, respectively; LPS, lipopolysaccharide; PBS, phosphate-buffered saline; PD-1−/−, programmed death-1 (PD-1) knockout mice; rTs-Cys, recombinant Trichinella spiralis cystatin; WT, wild-type mice
Fig. 11
Fig. 11
rTs-Cys promotes M2-type polarization of macrophages through the PD-1 pathway to improve MI in mice. a Intraperitoneal (i.P.) injection of rTs-Cys in MI mice effectively alleviates the inflammatory response in the damaged heart and mitigates MI symptoms. b rTs-Cys regulates the release of inflammatory cytokines from macrophages, thereby improving the inflammatory microenvironment of the heart, reducing myocardial fibrosis, and enhancing VEGF expression levels. This regulation is PD-1 dependent, C rTs-Cys improves cardiac function and tissue damage in MI mice by promoting the polarization of macrophages from the M1 to M2 phenotype through PD-1 regulation. α-SMAL, Alpha-smooth muscle actin; IL, interleukin; PD-1, programmed death-1; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; rTs-Cys, recombinant Trichinella spiralis cystatin; SV, stroke volume; TGF-β, transforming growth factor-beta; TNF-α, tumor necrosis factor-alpha; VEGF, vascular endothelial growth factor; WT, wild-type mice

Similar articles

References

    1. Murphy A, Goldberg S. Mechanical complications of myocardial infarction. Am J Med. 2022;135:1401–9. - PubMed
    1. Lindahl B, Mills NL. A new clinical classification of acute myocardial infarction. Nat Med. 2023;29:2200–5. - PubMed
    1. Bajaj A, Sethi A, Rathor P, et al. Acute complications of myocardial infarction in the current era: diagnosis and management. J Investig Med. 2015;63:844–55. - PubMed
    1. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147:e93–621. - PMC - PubMed
    1. Krittanawong C, Khawaja M, Tamis-Holland JE, et al. Acute myocardial infarction: etiologies and mimickers in young patients. J Am Heart Assoc. 2023;12:e029971. - PMC - PubMed